SHL Telemedicine confirms discussions regarding a possible merger or takeover transaction relating to the company

Tel Aviv / Zurich, 21 January 2020 – Following an article published in the Israeli financial press this morning, SHL Telemedicine Ltd. (SIX Swiss Exchange: SHLTN) (“SHL”), a leading provider and developer of advanced personal telemedicine solutions, has clarified today that it has been in discussions with a number of parties regarding a possible merger or takeover transaction relating to SHL. The parties include Danel Ltd., a public company listed at the Tel Aviv Stock Exhange. At this point, the parties have not yet taken any decision nor entered into any binding obligation with regard to the realization of such transaction. SHL will further inform the market as required. For more information Click here